NASDAQ:CYRN - Cyren Stock Price, Forecast & News

Cyren's stock was trading at $0.95 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CYRN stock has decreased by 16.3% and is now trading at $0.7950. View which stocks have been mosted impacted by Coronavirus.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cyren in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Cyren.

Cyren is scheduled to release its next quarterly earnings announcement on Wednesday, May 20th 2020. View our earnings forecast for Cyren.

Cyren Ltd (NASDAQ:CYRN) issued its earnings results on Wednesday, March, 25th. The technology company reported ($0.06) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.05) by $0.01. The technology company had revenue of $9.53 million for the quarter, compared to analysts' expectations of $9.90 million. Cyren had a negative return on equity of 74.01% and a negative net margin of 46.93%. View Cyren's earnings history.

1 brokers have issued twelve-month price objectives for Cyren's shares. Their forecasts range from $3.00 to $3.00. On average, they anticipate Cyren's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 277.4% from the stock's current price. View analysts' price targets for Cyren.

Press coverage about CYRN stock has been trending somewhat positive on Sunday, InfoTrie reports. The research group ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cyren earned a news sentiment score of 1.2 on InfoTrie's scale. They also assigned press coverage about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutCyren.

Cyren saw a decrease in short interest in March. As of March 13th, there was short interest totaling 23,600 shares, a decrease of 38.1% from the February 27th total of 38,100 shares. Based on an average daily trading volume, of 33,400 shares, the days-to-cover ratio is presently 0.7 days. Approximately 0.1% of the company's stock are sold short. View Cyren's Current Options Chain.

Some companies that are related to Cyren include Smith Micro Software (SMSI), Inspired Entertainment (INSE), DIRTT Environmental (DRTT), SharpSpring (SHSP), Medical Transcription Billing (MTBC), Aware (AWRE), Great Elm Capital Group (GEC), Where Food Comes From (WFCF), Astea International (ATEA), FalconStor Software (FALCD), Audioeye (AEYE), Mobivity (MFON), NetSol Technologies (NTWK), Datasea (DTSS) and Rego Payment Architectures (RPMT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cyren investors own include Actinium Pharmaceuticals (ATNM), NovaBay Pharmaceuticals (NBY), Athersys (ATHX), Biocept (BIOC), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), AVEO Pharmaceuticals (AVEO), Co-Diagnostics (CODX), Corbus Pharmaceuticals (CRBP) and Inpixon (INPX).

Cyren trades on the NASDAQ under the ticker symbol "CYRN."

Cyren's stock is owned by many different retail and institutional investors. Top institutional shareholders include Warburg Pincus LLC (54.30%), Renaissance Technologies LLC (1.14%), Belpointe Asset Management LLC (0.89%) and Meitav Dash Investments Ltd. (0.71%). Company insiders that own Cyren stock include Atif Ahmed, Joseph Michael Myshrall, Lior Samuelson and Sigurdur Arnar Stefnisson. View institutional ownership trends for Cyren.

CYRN stock was sold by a variety of institutional investors in the last quarter, including Meitav Dash Investments Ltd.. Company insiders that have sold Cyren company stock in the last year include Atif Ahmed, and Sigurdur Arnar Stefnisson. View insider buying and selling activity for Cyren.

CYRN stock was purchased by a variety of institutional investors in the last quarter, including Warburg Pincus LLC, Renaissance Technologies LLC, and Belpointe Asset Management LLC. View insider buying and selling activity for Cyren.

Shares of CYRN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CYRN stock can currently be purchased for approximately $0.80.

Cyren has a market capitalization of $47.16 million and generates $38.39 million in revenue each year. The technology company earns $-19,410,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis. Cyren employs 248 workers across the globe. View additional information about Cyren.

The official website for Cyren is http://www.cyren.com/.

Cyren's mailing address is 10 Ha-Menofim St. 5th Floor, Herzliya L3, 4672561. The technology company can be reached via phone at 972-9863-6888 or via email at [email protected]